Administration of exogeneous klotho protein or inducing endogenous production has led to promising outcomes in animal models, including reduction in the progression of acute kidney injury to CKD or attenuation of ischaemic renal injury [31, 32]. This evidence concerns the gene KL and chronic kidney disease.